| Předmět: |
|
| Zdroj: |
Immunotherapy Weekly; 11/07/2023, p755-755, 1p |
| Abstrakt: |
For more information on this research see: Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma. Keywords: Brentuximab Therapy; Brentuximab Vedotin Therapy; Cancer; Drugs and Therapies; Enzymes and Coenzymes; Health and Medicine; Hematology; Immunologic Agents; Immunoproliferative Disorders; Immunotherapy; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Monoclonal Antibodies; Oncology; Pharmaceuticals; Radiation Therapy; Transaminases EN Brentuximab Therapy Brentuximab Vedotin Therapy Cancer Drugs and Therapies Enzymes and Coenzymes Health and Medicine Hematology Immunologic Agents Immunoproliferative Disorders Immunotherapy Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Monoclonal Antibodies Oncology Pharmaceuticals Radiation Therapy Transaminases 755 755 1 11/06/23 20231107 NES 231107 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on lymphoma. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
